Sign in
CompletedNo phase

CGM in Patients With ED's

Key facts

Who runs it
Denver Health and Hospital Authority
Where
Denver, United StatesSee the site
Trial code
Status
Completed
People taking part
50 people enrolled
Started
9 May 2023
Ended
2 Jul 2024
Type of study
Observational
Treatments tested
  • Continuous Glucose Monitor
Record updated
5 February 2025

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Ages 18-65 and meet the DSM-V criteria for AN-R or AN-BP or ARFID
  • Admission %IBW ≤ 75%

Who cannot take part

  • Diagnosed with an eating disorder other than AN-R or AN-BP or ARFID
  • %IBW > 75% on admission
  • Inability to give informed consent to participate/lacks decisional capacity
  • Unable to follow the study protocol
  • Transferred to the unit on a mental health hold/short term certification
  • Treatment team refusal of patient's participation

Where in United States

  • Denver Health and Hospital AuthorityDenver, United States

About the trial

What the trial wants to find out

To determine the accuracy of continuous glucose monitoring (CGM) with point of care (POC) fingerstick glucose monitoring and venous blood glucose in patients with eating disorders, specifically anorexia nervosa, restricting subtype (AN-R); avoidant/restrictive food intake disorder (ARFID); and anorexia nervosa, binge/purge subtype (AN-BP).

The group in the trial

  • CGM

    Treatment: Continuous Glucose Monitor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Glucose Monitoring in Patients With Eating Disorders: A Pilot Study
Record updated
5 February 2025